University of Alberta
Edmonton, Alberta, T6G 2P4, Canada
NCT Number: NCT04389983
Assessing Ketone levels achieved after varying doses of Medium Chain Triglyceride (MCT) oil
Looking for future studies?
Notify Me21 year and older
All sexes
Interventional
Not applicable
Edmonton, Alberta, T6G 2P4, Canada
Assessing Ketone levels achieved after varying doses of Medium Chain Triglyceride (MCT) oil in three study populations: <65 year healthy, 65 and older healthy, and Alzheimer's disease.
Each subject attends for 4 study days, receiving incrementally larger MCT doses at each visit for 0g, to 14g, to 28g to 42g.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Bulletproof Braine Octane MCT oil
Time frame: 3 months
Calculation of Cmax to varying doses in each subject and in different study arms.
Time frame: 3 months
Calculation of tmax to varying doses in each subject and in different study arms.
Time frame: 3 months
Calculation of AUC to varying doses in each subject and in different study arms.
Time frame: 3months
measured in kg
Time frame: 3 months
measured in cm
Time frame: 3months
Calculated BMI (ht/m2)
Time frame: 3 months
% measured by bioimpedence scale
University of Alberta
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07560150
Insulin Aspart, Pharmacodynamics
Chula Vista, California, United States
View Trial DetailsNCT05142592
Pharmacokinetics, Safety Issues
Portland, Oregon, United States
View Trial DetailsNCT03911050
Human Health, Pharmacokinetics
Kannapolis, North Carolina, United States
View Trial DetailsNCT05328778
Pharmacokinetics
Guangzhou, Guangdong, China
View Trial Details